Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,260.00
+250.00 (2.77%)
Jan 20, 2026, 9:40 AM KST

Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 209.55 billion as of January 16, 2026. Its market cap has decreased by -14.43% in one year.

Market Cap
209.55B
Enterprise Value
171.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,260.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 209.55B, an increase of 30.77%. That is a compound annual growth rate of 5.17%.

History

DateMarket Cap% Change
Jan 16, 2026208.15B-10.41%
Dec 30, 2025232.34B-3.12%
Dec 30, 2024239.82B-53.54%
Dec 28, 2023516.20B-0.71%
Dec 29, 2022519.87B-21.31%
Dec 30, 2021660.68B-73.75%
Dec 30, 2020 Pro Pro
Sep 22, 2020 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition